BRO:NYSEBrown & Brown, Inc. Analysis
Data as of 2026-03-10 - not real-time
$68.58
Latest Price
6/10Risk
Risk Level: Medium
Executive Summary
Brown & Brown is trading well beneath its 20‑day, 50‑day and 200‑day moving averages, with a bearish price trend and a relative strength index hovering in the low‑mid‑30s, suggesting continued downside pressure but also a potential oversold condition. The stock is currently near a key support level just above $65 and faces resistance around $74, while volatility over the past month has spiked above 35%, and its beta is markedly low, indicating limited market‑wide correlation.
On the fundamentals side, the company posted robust revenue growth of roughly 36% YoY, healthy gross and operating margins, and strong cash generation that comfortably funds a modest 19% dividend payout. The DCF‑derived fair value exceeds $130, implying an upside of more than 20% versus today’s price, and a recent $250 million accelerated share‑repurchase program adds further price‑support. Analysts are largely neutral with a “hold” consensus, but the recent Mizuho upgrade to Outperform and the company’s low leverage relative to peers reinforce a longer‑term buying case.
On the fundamentals side, the company posted robust revenue growth of roughly 36% YoY, healthy gross and operating margins, and strong cash generation that comfortably funds a modest 19% dividend payout. The DCF‑derived fair value exceeds $130, implying an upside of more than 20% versus today’s price, and a recent $250 million accelerated share‑repurchase program adds further price‑support. Analysts are largely neutral with a “hold” consensus, but the recent Mizuho upgrade to Outperform and the company’s low leverage relative to peers reinforce a longer‑term buying case.
Market Outlook
Short Term
< 1 yearNeutral
Model confidence: 6/10
Key Factors
- Price below all major moving averages and near technical support
- Decreasing volume trend dampens short‑term momentum
- Share‑repurchase program provides a modest floor
Medium Term
1–3 yearsPositive
Model confidence: 7/10
Key Factors
- DCF upside of >20% and forward PE well below industry average
- Strong cash flow and low payout ratio support dividend sustainability
- Mizuho’s upgrade and limited AI disruption risk boost confidence
Long Term
> 3 yearsPositive
Model confidence: 8/10
Key Factors
- Consistent revenue growth and solid operating margins
- Robust balance sheet with manageable debt and ample liquidity
- Strategic position in insurance brokerage with low beta and defensive exposure
Key Metrics & Analysis
Financial Health
Revenue Growth36.20%
Profit Margin18.29%
P/E Ratio21.7
ROE11.23%
ROA4.24%
Debt/Equity62.98
P/B Ratio1.8
Op. Cash Flow$1.4B
Free Cash Flow$1.4B
Industry P/E17.3
Technical Analysis
TrendBearish
RSI38.0
Support$65.68
Resistance$73.80
MA 20$70.24
MA 50$74.39
MA 200$89.13
MACDBullish
VolumeDecreasing
Fear & Greed Index76.91
Valuation
Fair Value$136.68
Target Price$83.43
Upside/Downside21.65%
GradeUndervalued
TypeBlend
Dividend Yield0.89%
Risk Assessment
Beta0.31
Volatility38.77%
Sector RiskMedium
Reg. RiskMedium
Geo RiskMedium
Currency RiskLow
Liquidity RiskMedium
Similar Tickers
This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.